July 08, 2024
Community Shares | July 8th 2024
A new review has investigated the potential use of immunomodulating agents to treat neuroinflammation in patients with autism, who often do not respond to standard treatments. Neuroinflammation, influenced by genetic, epigenetic, and environmental factors, is considered a significant contributor to ASD. This work highlights that some existing anti-inflammatory treatments have shown promise, including corticosteroids, intravenous […]
